These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1555964)

  • 41. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of radiation shielding requirements for HDR brachytherapy using 169Yb and 192Ir sources.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Georgiou E; Hourdakis CJ; Baltas D
    Med Phys; 2006 Jul; 33(7):2541-7. PubMed ID: 16898458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water.
    Wuu CS; Chen J
    Radiat Prot Dosimetry; 2006; 122(1-4):506-8. PubMed ID: 17189276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radial dose distribution of 192Ir and 137Cs seed sources.
    Thomason C; Higgins P
    Med Phys; 1989; 16(2):254-7. PubMed ID: 2716705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. On the feasibility of polyurethane based 3D dosimeters with optical CT for dosimetric verification of low energy photon brachytherapy seeds.
    Adamson J; Yang Y; Juang T; Chisholm K; Rankine L; Adamovics J; Yin FF; Oldham M
    Med Phys; 2014 Jul; 41(7):071705. PubMed ID: 24989374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Samarium-145: a new brachytherapy source.
    Fairchild RG; Kalef-Ezra J; Packer S; Wielopolski L; Laster BH; Robertson JS; Mausner L; Kanellitsas C
    Phys Med Biol; 1987 Jul; 32(7):847-58. PubMed ID: 3615583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymer gel dosimetry close to an 125I interstitial brachytherapy seed.
    Pantelis E; Lymperopoulou G; Papagiannis P; Sakelliou L; Stiliaris E; Sandilos P; Seimenis I; Kozicki M; Rosiak JM
    Phys Med Biol; 2005 Sep; 50(18):4371-84. PubMed ID: 16148399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anisotropy functions for low energy interstitial brachytherapy sources: an EGS4 Monte Carlo study.
    Capote R; Mainegra E; López E
    Phys Med Biol; 2001 Jan; 46(1):135-50. PubMed ID: 11197668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radial dose distribution, dose to water and dose rate constant for monoenergetic photon point sources from 10 keV to 2 MeV:EGS4 Monte Carlo model calculation.
    Luxton G; Jozsef G
    Med Phys; 1999 Dec; 26(12):2531-8. PubMed ID: 10619236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131Cs.
    Melhus CS; Rivard MJ
    Med Phys; 2008 Jul; 35(7):3364-71. PubMed ID: 18697560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On the use of high dose rate 192Ir and 169Yb sources with the MammoSite radiation therapy system.
    Papagiannis P; Karaiskos P; Georgiou E; Baltas D; Lymperopoulou G; Pantelis E; Sakelliou L
    Med Phys; 2007 Sep; 34(9):3614-9. PubMed ID: 17926965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Attenuation of intracavitary applicators in 192Ir-HDR brachytherapy.
    Ye SJ; Brezovich IA; Shen S; Duan J; Popple RA; Pareek PN
    Med Phys; 2004 Jul; 31(7):2097-106. PubMed ID: 15305463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of source encapsulation on the energy spectra of 192Ir and 137Cs seed sources.
    Thomason C; Mackie TR; Lindstrom MJ
    Phys Med Biol; 1991 Apr; 36(4):495-505. PubMed ID: 2047398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polymer gel water equivalence and relative energy response with emphasis on low photon energy dosimetry in brachytherapy.
    Pantelis E; Karlis AK; Kozicki M; Papagiannis P; Sakelliou L; Rosiak JM
    Phys Med Biol; 2004 Aug; 49(15):3495-514. PubMed ID: 15379028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dosimetric study of a new polymer encapsulated palladium-103 seed.
    Bernard S; Vynckier S
    Phys Med Biol; 2005 Apr; 50(7):1493-504. PubMed ID: 15798339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monte Carlo study of correction factors for Spencer-Attix cavity theory at photon energies at or above 100 keV.
    Borg J; Kawrakow I; Rogers DW; Seuntjens JP
    Med Phys; 2000 Aug; 27(8):1804-13. PubMed ID: 10984227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Monte Carlo brachytherapy study for dose distribution prediction in an inhomogeneous medium.
    Slate LJ; Elson HR; Lamba MA; Kassing WM; Soldano M; Barrett WL
    Med Dosim; 2004; 29(4):271-8. PubMed ID: 15528069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monte Carlo-based investigation of absorbed-dose energy dependence of radiochromic films in high energy brachytherapy dosimetry.
    Subhalaxmi M; Selvam TP
    J Appl Clin Med Phys; 2014 Jan; 15(1):4448. PubMed ID: 24423841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.